Scientific Opinion on the substantiation of a health claim related to a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous-capillary permeability pursuant to Article 13(5) of Regulation (EC) No 1924/2006
Following an application from Omikron Italia S.r.l., submitted pursuant to Article 13.5 of Regulation (EC) No 1924/2006 via the Competent Authority of Italy, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health cla...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | EFSA Journal |
Subjects: | |
Online Access: | http://www.efsa.europa.eu/en/efsajournal/doc/3511.pdf |
_version_ | 1818617004572016640 |
---|---|
author | EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) |
author_facet | EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) |
author_sort | EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) |
collection | DOAJ |
description | Following an application from Omikron Italia S.r.l., submitted pursuant to Article 13.5 of Regulation (EC) No 1924/2006 via the Competent Authority of Italy, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous-capillary permeability. The food that is a subject of the health claim, a combination of diosmin, troxerutin and hesperidin, is sufficiently characterised. The claimed effect, maintenance of normal venous-capillary permeability, is a beneficial physiological effect. No human intervention studies from which conclusions could be drawn for the scientific substantiation of the claim were provided by the applicant. The Panel concludes that a cause and effect relationship has not been established between the consumption of a combination of diosmin, troxerutin and hesperidin and the maintenance of normal venous-capillary permeability. |
first_indexed | 2024-12-16T16:58:48Z |
format | Article |
id | doaj.art-60c0e70bbf0f404ca0c3ff172aee8d56 |
institution | Directory Open Access Journal |
issn | 1831-4732 |
language | English |
last_indexed | 2024-12-16T16:58:48Z |
publishDate | 2014-01-01 |
publisher | Wiley |
record_format | Article |
series | EFSA Journal |
spelling | doaj.art-60c0e70bbf0f404ca0c3ff172aee8d562022-12-21T22:23:49ZengWileyEFSA Journal1831-47322014-01-0112110.2903/j.efsa.2014.3511EFSA Journal 2014;12(1):3511Scientific Opinion on the substantiation of a health claim related to a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous-capillary permeability pursuant to Article 13(5) of Regulation (EC) No 1924/2006EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)Following an application from Omikron Italia S.r.l., submitted pursuant to Article 13.5 of Regulation (EC) No 1924/2006 via the Competent Authority of Italy, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous-capillary permeability. The food that is a subject of the health claim, a combination of diosmin, troxerutin and hesperidin, is sufficiently characterised. The claimed effect, maintenance of normal venous-capillary permeability, is a beneficial physiological effect. No human intervention studies from which conclusions could be drawn for the scientific substantiation of the claim were provided by the applicant. The Panel concludes that a cause and effect relationship has not been established between the consumption of a combination of diosmin, troxerutin and hesperidin and the maintenance of normal venous-capillary permeability.http://www.efsa.europa.eu/en/efsajournal/doc/3511.pdfdiosmintroxerutinhesperidinvenous permeabilityhealth claims |
spellingShingle | EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Scientific Opinion on the substantiation of a health claim related to a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous-capillary permeability pursuant to Article 13(5) of Regulation (EC) No 1924/2006 EFSA Journal diosmin troxerutin hesperidin venous permeability health claims |
title | Scientific Opinion on the substantiation of a health claim related to a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous-capillary permeability pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
title_full | Scientific Opinion on the substantiation of a health claim related to a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous-capillary permeability pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
title_fullStr | Scientific Opinion on the substantiation of a health claim related to a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous-capillary permeability pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
title_full_unstemmed | Scientific Opinion on the substantiation of a health claim related to a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous-capillary permeability pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
title_short | Scientific Opinion on the substantiation of a health claim related to a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous-capillary permeability pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
title_sort | scientific opinion on the substantiation of a health claim related to a combination of diosmin troxerutin and hesperidin and maintenance of normal venous capillary permeability pursuant to article 13 5 of regulation ec no 1924 2006 |
topic | diosmin troxerutin hesperidin venous permeability health claims |
url | http://www.efsa.europa.eu/en/efsajournal/doc/3511.pdf |
work_keys_str_mv | AT efsapanelondieteticproductsnutritionandallergiesnda scientificopiniononthesubstantiationofahealthclaimrelatedtoacombinationofdiosmintroxerutinandhesperidinandmaintenanceofnormalvenouscapillarypermeabilitypursuanttoarticle135ofregulationecno19242006 |